Search results for: 'software revenue model'
- Did you mean
- software revenue m9de
- software revenue m8de
- Related search terms
- Software-Defined Instruments and Reinvented Business Models to Impact Market Outlook, Communication Test Revenues to Soar
- model based system engineering iot (big data) fleet operation
- revenue estimates for payment fraud prevention services
- Modeling software market
- revenue is projected to decline by 5.0% in 2023, attributed to the reduced demand for COVID-19-related test
-
28 Apr 2017  |  Asia Pacific  |  Market Research
End-user and Decision-maker Survey of Southeast Asian PACS Market, Forecast to 2021
Revenue Opportunities Continue to Exist Even as Market Advances toward Vendor-neutral Solutions
The research service provides an in-depth analysis of the Picture Archiving and Communication System (PACS) market across six Southeast Asian countries with a focus on end-user and radiology decision-maker needs, challenges, and vendor preferences. The study provides opportunity analysis, vendor landscape, and evolving technology and business model...
$4,950.00 -
31 Jan 2022  |  Asia Pacific  |  Market Research
Enterprise Imaging Partnerships and Growth Opportunities in Selected Asia-Pacific Countries
New Business Models Overcome Budget Restrictions to Enable Equipment Purchase and Management
In this report, Frost & Sullivan analyzes emerging business models in the medical imaging industry in Asia-Pacific, focusing on India, Australia, Vietnam, Indonesia, and Singapore. Conventional business models that focus on selling products based on specification superiority or unique selling propositions are forecast to slow down. Requirement chan...
$2,450.00 -
07 Feb 2020  |  Asia Pacific  |  Market Research
Malaysian Diabetes Devices Market, Forecast to 2023
Service Models that Address Affordability are the Preferred Models in this Cost-sensitive Market
Diabetes is a growing concern globally, with more than 425 million people suffering the world over. Malaysia is no exception. It has a very high prevalence of about 16%; there were an estimated 3.57 million diabetics in the country in 2018. Unfortunately, only about 50% of this population is actually diagnosed, meaning half of those diabetics are d...
$3,000.00 -
03 Jul 2015  |  Asia Pacific  |  Market Research
Analysis of The Telemedicine Market in Asia-Pacific
Affordable Telemedicine Services Are Enabling Business Model Evolution
Telemedicine is not a new concept in healthcare; it has been practiced in the form of pilots and charitable projects for over a decade across Asia-Pacific countries. However, recent advancements in information and communication technologies have led to a significant decrease in the costs associated with telemedicine, spurring a sudden market boom. ...
$3,950.00 -
11 Nov 2016  |  Asia Pacific  |  Market Research
Analysis of the Australian Clinical Laboratory Market
Evolving Business Model—Technological Advances will Drive the Market
Given the ever increasing cost of care, healthcare delivery is moving towards decentralisation. Service delivery from healthcare settings such as mobile clinics, rapid retail clinics, and home settings demands the use of new-age clinical laboratory diagnostics. The effective delivery of healthcare services has created a business and technology conv...
$1,500.00 -
24 Jan 2017  |  Asia Pacific  |  Market Research
Game-changing Strategies of APAC Pharma Companies
Growing Focus on Specific Therapy Areas and Shift Towards Value-based Delivery Model Expected to Boost Pharma Market
Frost & Sullivan has recently completed a comprehensive analysis on the current and future strategic imperatives of game-changing Asia-Pacific (APAC) pharmaceutical companies. The analysis primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing...
$1,500.00 -
11 Oct 2017  |  Asia Pacific  |  Market Research
Australian Retail Technology Report, 2016–2021
Australian Retail Technology Offers Sizeable Growth Opportunities
Retail technology investment in Australia is projected to record a CAGR of 28.8% from 2016-2021 largely driven by evolving consumer requirements and intensifying retail competition from international entrants and new business models. These factors are set to raise standards across both the front and back ends of retail technology. Current investmen...
$3,000.00 -
11 May 2020  |  Asia Pacific  |  Market Outlook
Outlook of India’s Healthcare Industry, 2020
Indian Healthcare Industry is Expected to Grow at 16.9% in 2020 to Reach $272.79 Billion in 2020
The study covers the healthcare market which develops and provides products, solutions, and/or services across the care spectrum for diagnosis, treatment, and prevention. The biosimilars market in India is expected to cross $0.9 billion by 2020. The growing prevalence of chronic diseases with an increasing aged population in India and globally, c...
$4,950.00 -
20 Apr 2023  |  Asia Pacific  |  Market Outlook
Asia-Pacific Next-generation Diagnostics Outlook, 2023
The Renewed Focus on Infectious Diseases Outside COVID-9, Oncology, Cardiovascular, Diabetes, and Prenatal Care will Drive Market Growth
The Asia-Pacific next-generation diagnostics market's revenue is projected to decline by 5.0% in 2023, attributed to the reduced demand for COVID-19-related testing. Rapid expansion in non-COVID molecular diagnostics and point-of-care testing (POCT) will not be sufficient to drive the overall recovery of the region. As companies continue to focus o...
$4,950.00 -
06 May 2016  |  Asia Pacific  |  Market Research
Global Generic Pharmaceuticals Market, Forecast to 2020
Market Participants Target High Value-added Branded Generics and Biosimilars Segments
The key objectives of this research service are to gain an in-depth knowledge of the major markets and therapeutic areas and organizations presenting significant growth opportunities for generics, to understand the impact of regulation on the market, and to outline the industry consolidation trends that will continue shaping the future of generics....
$4,950.00